Aarajana Shrestha

718 total citations
35 papers, 627 citations indexed

About

Aarajana Shrestha is a scholar working on Molecular Biology, Toxicology and Organic Chemistry. According to data from OpenAlex, Aarajana Shrestha has authored 35 papers receiving a total of 627 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 20 papers in Toxicology and 13 papers in Organic Chemistry. Recurrent topics in Aarajana Shrestha's work include Cancer therapeutics and mechanisms (21 papers), Bioactive Compounds and Antitumor Agents (20 papers) and Synthesis and bioactivity of alkaloids (10 papers). Aarajana Shrestha is often cited by papers focused on Cancer therapeutics and mechanisms (21 papers), Bioactive Compounds and Antitumor Agents (20 papers) and Synthesis and bioactivity of alkaloids (10 papers). Aarajana Shrestha collaborates with scholars based in South Korea, United States and Japan. Aarajana Shrestha's co-authors include Tara Man Kadayat, Ganesh Bist, Youngjoo Kwon, Til Bahadur Thapa Magar, Eung-Seok Lee, Eung-Seok Lee, Seojeong Park, Younghwa Na, Pil‐Hoon Park and Hyunji Jo and has published in prestigious journals such as Chemical Communications, International Journal of Molecular Sciences and Journal of Medicinal Chemistry.

In The Last Decade

Aarajana Shrestha

35 papers receiving 622 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Aarajana Shrestha South Korea	19	334	330	107	98	95	35	627
Sultan Nacak Baytaş Türkiye	17	477 1.4×	267 0.8×	46 0.4×	84 0.9×	51 0.5×	34	694
Til Bahadur Thapa Magar South Korea	16	274 0.8×	266 0.8×	109 1.0×	72 0.7×	80 0.8×	31	536
Saleh Ihmaid Saudi Arabia	24	884 2.6×	442 1.3×	64 0.6×	93 0.9×	119 1.3×	39	1.1k
Zhuang Hou China	17	412 1.2×	339 1.0×	62 0.6×	95 1.0×	47 0.5×	39	708
Jo‐Anne de la Mare South Africa	15	197 0.6×	255 0.8×	62 0.6×	37 0.4×	160 1.7×	32	577
G. Bharath Kumar India	19	695 2.1×	286 0.9×	63 0.6×	102 1.0×	75 0.8×	30	888
Ehab M. Gedawy Egypt	14	405 1.2×	303 0.9×	62 0.6×	87 0.9×	89 0.9×	29	640
Ying-Qian Liu China	14	188 0.6×	313 0.9×	66 0.6×	45 0.5×	87 0.9×	17	456
Viswanath Arutla India	15	571 1.7×	265 0.8×	58 0.5×	65 0.7×	57 0.6×	27	774
Mahmoud F. Abo-Ashour Egypt	18	832 2.5×	675 2.0×	73 0.7×	183 1.9×	106 1.1×	22	1.0k

Countries citing papers authored by Aarajana Shrestha

Since Specialization

Citations

This map shows the geographic impact of Aarajana Shrestha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aarajana Shrestha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aarajana Shrestha more than expected).

Fields of papers citing papers by Aarajana Shrestha

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aarajana Shrestha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aarajana Shrestha. The network helps show where Aarajana Shrestha may publish in the future.

Co-authorship network of co-authors of Aarajana Shrestha

This figure shows the co-authorship network connecting the top 25 collaborators of Aarajana Shrestha. A scholar is included among the top collaborators of Aarajana Shrestha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aarajana Shrestha. Aarajana Shrestha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lee, Su Min, et al.. (2022). Potent inhibitory activity of hydroxylated 2-benzylidene-3,4-dihydronaphthalen-1(2H)-ones on LPS-stimulated reactive oxygen species production in RAW 264.7 macrophages. Bioorganic & Medicinal Chemistry Letters. 73. 128921–128921. 4 indexed citations

Hwang, Soo‐Yeon, Aarajana Shrestha, Seojeong Park, et al.. (2021). Identification of new halogen-containing 2,4-diphenyl indenopyridin-5-one derivative as a boosting agent for the anticancer responses of clinically available topoisomerase inhibitors. European Journal of Medicinal Chemistry. 227. 113916–113916. 10 indexed citations

Shrestha, Aarajana, Su‐Jeong Lee, Yong Hyun Jeon, et al.. (2021). Targeting the Nuclear Receptor-Binding SET Domain Family of Histone Lysine Methyltransferases for Cancer Therapy: Recent Progress and Perspectives. Journal of Medicinal Chemistry. 64(20). 14913–14929. 23 indexed citations

Magar, Til Bahadur Thapa, et al.. (2021). Synthesis and structure-activity relationships of hydroxylated and halogenated 2,4-diaryl benzofuro[3,2-b]pyridin-7-ols as selective topoisomerase IIα inhibitors. Bioorganic Chemistry. 111. 104884–104884. 6 indexed citations

Kadayat, Tara Man, Aarajana Shrestha, Yong Hyun Jeon, et al.. (2020). Targeting Peroxisome Proliferator-Activated Receptor Delta (PPARδ): A Medicinal Chemistry Perspective. Journal of Medicinal Chemistry. 63(18). 10109–10134. 20 indexed citations

Shrestha, Aarajana, Tae‐Ho Lee, Ju‐Hyun Kim, et al.. (2019). Assessing Drug Interaction and Pharmacokinetics of Loxoprofen in Mice Treated with CYP3A Modulators. Pharmaceutics. 11(9). 479–479. 6 indexed citations

Shrestha, Aarajana, et al.. (2019). Introduction of amino moiety enhances the inhibitory potency of 1-tetralone chalcone derivatives against LPS-stimulated reactive oxygen species production in RAW 264.7 macrophages. Bioorganic Chemistry. 87. 495–505. 17 indexed citations

Kadayat, Tara Man, Suhrid Banskota, Ganesh Bist, et al.. (2018). Synthesis and biological evaluation of pyridine-linked indanone derivatives: Potential agents for inflammatory bowel disease. Bioorganic & Medicinal Chemistry Letters. 28(14). 2436–2441. 14 indexed citations

Shrestha, Aarajana, et al.. (2018). Design and Synthesis of Fluorinated and/or Hydroxylated 2‐Arylidene‐1‐indanone Derivatives as an Inhibitor of LPS‐stimulated ROS Production in RAW 264.7 Macrophages with Structure–Activity Relationship Study. Bulletin of the Korean Chemical Society. 39(12). 1432–1441. 3 indexed citations

10.

Shrestha, Aarajana, Seojeong Park, Tara Man Kadayat, et al.. (2018). Design, synthesis, biological evaluation, structure-activity relationship study, and mode of action of 2-phenol-4,6-dichlorophenyl-pyridines. Bioorganic Chemistry. 79. 1–18. 18 indexed citations

11.

Magar, Til Bahadur Thapa, Tara Man Kadayat, Hyunji Jo, et al.. (2018). Synthesis and SAR study of new hydroxy and chloro-substituted 2,4-diphenyl 5H-chromeno[4,3-b]pyridines as selective topoisomerase IIα-targeting anticancer agents. Bioorganic & Medicinal Chemistry. 26(8). 1909–1919. 19 indexed citations

12.

Magar, Til Bahadur Thapa, Tara Man Kadayat, Seojeong Park, et al.. (2017). 2-Chlorophenyl-substituted benzofuro[3,2-b]pyridines with enhanced topoisomerase inhibitory activity: The role of the chlorine substituent. Bioorganic & Medicinal Chemistry Letters. 27(15). 3279–3283. 20 indexed citations

13.

Bist, Ganesh, Nirmala Tilija Pun, Til Bahadur Thapa Magar, et al.. (2017). Inhibition of LPS-stimulated ROS production by fluorinated and hydroxylated chalcones in RAW 264.7 macrophages with structure-activity relationship study. Bioorganic & Medicinal Chemistry Letters. 27(5). 1205–1209. 30 indexed citations

14.

Bist, Ganesh, Seojeong Park, Til Bahadur Thapa Magar, et al.. (2017). Dihydroxylated 2,6-diphenyl-4-chlorophenylpyridines: Topoisomerase I and IIα dual inhibitors with DNA non-intercalative catalytic activity. European Journal of Medicinal Chemistry. 133. 69–84. 21 indexed citations

15.

Karki, Radha, Kyu-Yeon Jun, Tara Man Kadayat, et al.. (2016). A new series of 2-phenol-4-aryl-6-chlorophenyl pyridine derivatives as dual topoisomerase I/II inhibitors: Synthesis, biological evaluation and 3D-QSAR study. European Journal of Medicinal Chemistry. 113. 228–245. 22 indexed citations

16.

Kadayat, Tara Man, Seojeong Park, Til Bahadur Thapa Magar, et al.. (2016). Synthesis and biological evaluation of 2-phenol-4-chlorophenyl-6-aryl pyridines as topoisomerase II inhibitors and cytotoxic agents. Bioorganic Chemistry. 66. 145–159. 13 indexed citations

17.

Park, Seojeong, Tara Man Kadayat, Til Bahadur Thapa Magar, et al.. (2016). Novel 2-aryl-4-(4′-hydroxyphenyl)-5H-indeno[1,2-b]pyridines as potent DNA non-intercalative topoisomerase catalytic inhibitors. European Journal of Medicinal Chemistry. 125. 14–28. 24 indexed citations

18.

Kadayat, Tara Man, Seojeong Park, Kyu-Yeon Jun, et al.. (2016). Effect of chlorine substituent on cytotoxic activities: Design and synthesis of systematically modified 2,4-diphenyl-5H-indeno[1,2-b]pyridines. Bioorganic & Medicinal Chemistry Letters. 26(7). 1726–1731. 19 indexed citations

19.

Kadayat, Tara Man, Til Bahadur Thapa Magar, Ganesh Bist, et al.. (2015). Synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure–activity relationship study of 2-phenyl- or hydroxylated 2-phenyl-4-aryl-5H-indeno[1,2-b]pyridines. Bioorganic & Medicinal Chemistry. 23(13). 3499–3512. 25 indexed citations

20.

Karki, Radha, Tara Man Kadayat, Til Bahadur Thapa Magar, et al.. (2015). Topoisomerase I and II inhibitory activity, cytotoxicity, and structure–activity relationship study of dihydroxylated 2,6-diphenyl-4-aryl pyridines. Bioorganic & Medicinal Chemistry. 23(13). 3638–3654. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact